Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma.
Journal: JCO precision oncology
Published: April 22, 2026
Complementary Chinese Herbal Medicine Use and Gastrointestinal Cancers: A Scoping Review of Usage Patterns and Survival Outcomes in Taiwanese Population-Based Studies.
Journal: Current oncology reports
Published: July 08, 2025
Electro-acupuncture for quality of life during adjuvant chemotherapy in gastric cancer: a randomized trial.
Journal: Journal of the National Cancer Institute
Published: May 22, 2025
Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 07, 2024
PD-L1 Immunohistochemistry in Gastric Cancer: Comparison of Combined Positive Score and Tumor Area Positivity Across 28-8, 22C3, and SP263 Assays.
Journal: JCO precision oncology
Published: June 01, 2024
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases.
Journal: Oncoimmunology
Published: December 21, 2023
18F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 09, 2023
Immunotherapy for Resectable Locally Advanced Esophageal Carcinoma.
Journal: The Annals of thoracic surgery
Published: October 30, 2023
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.
Journal: The Lancet. Oncology
Published: May 12, 2023
HER2 Targeting in Esophagogastric Cancer: Redefining the Landscape and Breaking Barriers.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 16, 2022
Durvalumab consolidation therapy in a patient with stage IIIB unresectable NSCLC harboring a MET exon 14 splice site alteration.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 14, 2021
Haploidentical Hematopoietic Stem Cell Transplantation Followed by 'Post-Cyclophosphamide': The Future of Allogeneic Stem Cell Transplant.
Journal: Clinical hematology international
Published: February 05, 2020
Last Updated: 09/26/2026